ZyStor Therapeutics Overview

Life ScienceCompany

Was ZyStor Therapeutics formerly PE-backed?

Yes. ZyStor Therapeutics was formerly owned by 1 private investor.

Where is ZyStor Therapeutics headquartered?

ZyStor Therapeutics is headquartered in Milwaukee, Wisconsin.

What sector is ZyStor Therapeutics in?

ZyStor Therapeutics is a life science company.

ZyStor Therapeutics, Inc.

10437 Innovation Drive Suite 100,
Milwaukee, Wisconsin 53226-4838
United States,
(414) 727-9777
www.zystor.com

ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs). ZyStor employs a novel, proprietary technology which improves the delivery of therapeutics that replace the missing lysosomal enzyme in LSD patients. ZyStor has demonstrated in cell culture and in a well-characterized animal model that this technology provides several distinct advantages over other LSD therapeutics in use today.



Try Mergr Free — See This and 221,469+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.